Compare FDMT & BRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FDMT | BRR |
|---|---|---|
| Founded | 2013 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 391.8M | 344.8M |
| IPO Year | 2020 | N/A |
| Metric | FDMT | BRR |
|---|---|---|
| Price | $10.99 | $3.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $30.33 | N/A |
| AVG Volume (30 Days) | 767.4K | ★ 1.8M |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,000.00 | N/A |
| Revenue This Year | $21,181.08 | N/A |
| Revenue Next Year | $162.43 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 605.88 | N/A |
| 52 Week Low | $2.24 | $3.32 |
| 52 Week High | $12.34 | $16.25 |
| Indicator | FDMT | BRR |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | N/A |
| Support Level | $10.30 | N/A |
| Resistance Level | $11.50 | N/A |
| Average True Range (ATR) | 0.70 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 56.85 | 0.00 |
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Columbus Circle Capital Corp I is a blank check company.